Immunovant, Inc. IMVT Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Immunovant, Inc.’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s accounts payable?
- Immunovant, Inc. (IMVT) reported accounts payable of $7.54M in Q1 2026.
- How has Immunovant, Inc.'s accounts payable changed year-over-year?
- Immunovant, Inc.'s accounts payable decreased by 57.3% year-over-year, from $17.66M to $7.54M.
- What is the long-term trend for Immunovant, Inc.'s accounts payable?
- Over 5 years (2021 to 2026), Immunovant, Inc.'s accounts payable has grown at a 25.4% compound annual growth rate (CAGR), from $2.43M to $7.54M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.